OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares
Kenneth G. Saag, Puja Khanna, Robert T. Keenan, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 8, pp. 1533-1542
Open Access | Times Cited: 63
Kenneth G. Saag, Puja Khanna, Robert T. Keenan, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 8, pp. 1533-1542
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker
Hang‐Korng Ea, Brenda Kischkel, T.W. Chirayath, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 945-956
Closed Access | Times Cited: 17
Hang‐Korng Ea, Brenda Kischkel, T.W. Chirayath, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 945-956
Closed Access | Times Cited: 17
Gout therapeutics and drug delivery
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 28
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 28
Controversies and practical management of patients with gout and chronic kidney disease
Richard J. Johnson, Brian F. Mandell, Naomi Schlesinger, et al.
Kidney International (2024) Vol. 106, Iss. 4, pp. 573-582
Closed Access | Times Cited: 13
Richard J. Johnson, Brian F. Mandell, Naomi Schlesinger, et al.
Kidney International (2024) Vol. 106, Iss. 4, pp. 573-582
Closed Access | Times Cited: 13
Gouty Arthropathy: Review of Clinical Manifestations and Treatment, with Emphasis on Imaging
Jennifer S. Weaver, Ernest R. Vina, Peter L. Munk, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 166-166
Open Access | Times Cited: 43
Jennifer S. Weaver, Ernest R. Vina, Peter L. Munk, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 166-166
Open Access | Times Cited: 43
Immune and inflammatory mechanisms and therapeutic targets of gout: An update
Wenji Liu, Jie Peng, Yixin Wu, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110466-110466
Closed Access | Times Cited: 21
Wenji Liu, Jie Peng, Yixin Wu, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110466-110466
Closed Access | Times Cited: 21
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
Naomi Schlesinger, Michael H. Pillinger, Lee S. Simon, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 21
Naomi Schlesinger, Michael H. Pillinger, Lee S. Simon, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 21
Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions
Shuangling Yang, Haimei Liu, Xian-Ming Fang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111932-111932
Open Access | Times Cited: 8
Shuangling Yang, Haimei Liu, Xian-Ming Fang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111932-111932
Open Access | Times Cited: 8
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
Ruixue Kong, Lulu Sun, Hua Li, et al.
Autoimmunity (2021) Vol. 55, Iss. 1, pp. 1-7
Closed Access | Times Cited: 35
Ruixue Kong, Lulu Sun, Hua Li, et al.
Autoimmunity (2021) Vol. 55, Iss. 1, pp. 1-7
Closed Access | Times Cited: 35
A glance into the future of gout
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Microneedle transdermal drug delivery as a candidate for the treatment of gouty arthritis: Material structure, design strategies and prospects
Yi Hong, Haojie Yu, Li Wang, et al.
Acta Biomaterialia (2024) Vol. 187, pp. 20-50
Closed Access | Times Cited: 5
Yi Hong, Haojie Yu, Li Wang, et al.
Acta Biomaterialia (2024) Vol. 187, pp. 20-50
Closed Access | Times Cited: 5
Emerging strategies for treating gout
Edward M. Huddleston, Angelo Gaffo
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102241-102241
Closed Access | Times Cited: 22
Edward M. Huddleston, Angelo Gaffo
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102241-102241
Closed Access | Times Cited: 22
Constitutive IL-1RA production by modified immune cells protects against IL-1–mediated inflammatory disorders
Mariasilvia Colantuoni, Raisa Jofra Hernández, Emanuela Pettinato, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 698
Closed Access | Times Cited: 13
Mariasilvia Colantuoni, Raisa Jofra Hernández, Emanuela Pettinato, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 698
Closed Access | Times Cited: 13
Gout and its management
Nicola Dalbeth, Leanne Te Karu, Lisa K. Stamp
Internal Medicine Journal (2024) Vol. 54, Iss. 5, pp. 716-723
Open Access | Times Cited: 4
Nicola Dalbeth, Leanne Te Karu, Lisa K. Stamp
Internal Medicine Journal (2024) Vol. 54, Iss. 5, pp. 716-723
Open Access | Times Cited: 4
Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis
Hong Ki Min, Se Hee Kim, Hae‐Rim Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13913-13913
Open Access | Times Cited: 19
Hong Ki Min, Se Hee Kim, Hae‐Rim Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13913-13913
Open Access | Times Cited: 19
The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice
Po‐Yi Paul Su, Lingyi Zhang, Liangliang He, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 2223-2248
Open Access | Times Cited: 18
Po‐Yi Paul Su, Lingyi Zhang, Liangliang He, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 2223-2248
Open Access | Times Cited: 18
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
Sicylle Jeria-Navarro, Alejandro Gómez‐Gómez, Hye Sang Park, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 10
Sicylle Jeria-Navarro, Alejandro Gómez‐Gómez, Hye Sang Park, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 10
A randomized controlled pilot trial of anakinra for hemodialysis inflammation
Laura M. Dember, Adriana M. Hung, Rajnish Mehrotra, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. 1178-1187
Open Access | Times Cited: 15
Laura M. Dember, Adriana M. Hung, Rajnish Mehrotra, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. 1178-1187
Open Access | Times Cited: 15
Pipeline Therapies for Gout
Kevin Yip, Genna Braverman, Linda Yue, et al.
Current Rheumatology Reports (2023) Vol. 26, Iss. 3, pp. 69-80
Closed Access | Times Cited: 8
Kevin Yip, Genna Braverman, Linda Yue, et al.
Current Rheumatology Reports (2023) Vol. 26, Iss. 3, pp. 69-80
Closed Access | Times Cited: 8
Gout Management Using Nanocarrier Systems: A Review
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 9, pp. 9816-9846
Closed Access | Times Cited: 3
Chia Wen Qi, Ummu Umaimah Mohd Nordin, Syed Mahmood, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 9, pp. 9816-9846
Closed Access | Times Cited: 3
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Xiaowei Sun, Rou Gu, Jie Bai
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Xiaowei Sun, Rou Gu, Jie Bai
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Treatment advances in gout
Lisa K. Stamp, Hamish Farquhar
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 4, pp. 101719-101719
Closed Access | Times Cited: 20
Lisa K. Stamp, Hamish Farquhar
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 4, pp. 101719-101719
Closed Access | Times Cited: 20
Gout Flare Burden, Diagnosis, and Management: Navigating Care in Older Patients with Comorbidity
Mukund Kumar, Natalie Manley, Ted R. Mikuls
Drugs & Aging (2021) Vol. 38, Iss. 7, pp. 545-557
Closed Access | Times Cited: 18
Mukund Kumar, Natalie Manley, Ted R. Mikuls
Drugs & Aging (2021) Vol. 38, Iss. 7, pp. 545-557
Closed Access | Times Cited: 18
Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis
Chenfeng Wang, Hongdao Ma, Bangke Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Chenfeng Wang, Hongdao Ma, Bangke Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
